Evidence map›Paper›PMID 41899630›Full record

ArticleCancers2026

Study-International Multicentric Minimally Invasive Liver Resection (SIMMILR-5): A Comparison of Open, Conventional Laparoscopic and Tele-Robotic Laparoscopic Liver Resection for Hepatocellular Cancer.

Andrew A Gumbs, Roland Croner, David Fuks, Hadrien Tranchart, Zacharias Heger Londono, Joseph Derienne, Albert Chomątowski, Amir Nour Mohammadi, Vincent Grasso, Soufyan El Adel and 4 more

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Andrew A GumbsHôpital Antoine Béclère, Assistance Publique-Hôpitaux de Paris, 157 Rue de la Porte de Trivaux, 92140 Clamart, France.ORCID 0000-0002-7044-5318
Roland CronerDepartment of General-, Visceral-, Vascular- and Transplantation Surgery, University of Magdeburg, 39120 Magdeburg, Germany.ORCID 0000-0001-6248-7086
David FuksDepartment of Visceral Surgery, CHUV-UNIL, Rue du Bugnon 46, 1005 Lausanne, Switzerland.
Hadrien TranchartHôpital Antoine Béclère, Assistance Publique-Hôpitaux de Paris, 157 Rue de la Porte de Trivaux, 92140 Clamart, France.
Zacharias Heger LondonoDepartment of Visceral Surgery, CHUV-UNIL, Rue du Bugnon 46, 1005 Lausanne, Switzerland.
Joseph DerienneHôpital Antoine Béclère, Assistance Publique-Hôpitaux de Paris, 157 Rue de la Porte de Trivaux, 92140 Clamart, France.ORCID 0000-0002-2562-6507
Albert ChomątowskiDepartment of Surgical Oncology, Medical University of Lublin, Radziwiłłowska 13 St., 20-080 Lublin, Poland.ORCID 0009-0005-5667-5570
Amir Nour MohammadiDepartment of Surgical Oncology, Medical University of Lublin, Radziwiłłowska 13 St., 20-080 Lublin, Poland.ORCID 0009-0009-2710-513X
Vincent GrassoDepartment of Electrical and Computer Engineering, University of New Mexico, Albuquerque, NM 87106, USA.
Soufyan El AdelDepartment of Surgery, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Gianfranco DonatelliUnité d'Endoscopie Interventionnelle, Hôpital Privé des Peupliers, 75013 Paris, France.ORCID 0000-0003-0645-1710
Karol Rawicz-PruzynskiDepartment of Surgical Oncology, Medical University of Lublin, Radziwiłłowska 13 St., 20-080 Lublin, Poland.ORCID 0000-0002-2555-2114
Mohammad Abu-HilalDepartment of Surgery, School of Medicine, The University of Jordan, Amman 11942, Jordan.ORCID 0000-0002-3162-4639
Ibrahim DagherHôpital Antoine Béclère, Assistance Publique-Hôpitaux de Paris, 157 Rue de la Porte de Trivaux, 92140 Clamart, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe role of minimally invasive surgery (MIS) for hepatocellular carcinoma (HCC) remains controversial because of concerns regarding oncologic adequacy, particularly margin status. While robotic-assisted hepatectomy has gained adoption, its true perioperative advantages over conventional laparoscopy and open surgery remain unclear. SIMMILR-5 was designed to evaluate the short-term outcomes of open, laparoscopic, and tele-robotic laparoscopic hepatectomy for HCC using rigorous adjustment for confounding.

methodsA retrospective international multicenter study was conducted including patients undergoing liver resection for HCC between June 2004 and November 2024 at five high-volume hepatobiliary centers. Surgical approaches included open (O), conventional laparoscopy (L), and tele-robotic laparoscopy (TRL). Propensity score matching was performed using demographic, clinical, and tumor-related variables. The primary endpoint was short-term mortality (30 and 90 days). Secondary outcomes included estimated blood loss (EBL), operative time, length of stay (LOS), R0 resection status, and major complications.

resultsA total of 904 patients were identified (302 O, 568 L, 34 TRL). After matching, conventional laparoscopy was associated with significantly lower EBL, shorter operative time, and shorter LOS compared with open surgery (all

conclusionsMinimally invasive hepatectomy offers perioperative advantages over open surgery for selected patients with HCC, driven primarily by conventional laparoscopy. Tele-robotic hepatectomy is feasible and safe in experienced centers but does not demonstrate superiority over advanced laparoscopic techniques.

Indexed as

3D laparoscopycobotic-assisted surgerycoboticscollaborative robotic laparoscopyconventional laparoscopydigitally enhanced laparoscopyhepatectomyhepatocellular (HCC)liver resectionprimary liver cancertele-robotic laparoscopic surgery

Identifiers

PMID41899630
PMCPMC13025891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.